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Quantitative Proton Spectroscopic Imaging of the
Neurochemical Proﬁle in Rat Brain with Microliter
Resolution at Ultra-short Echo Times
Vladimı´r Mlyna´rik,1* Ingrid Kohler,1 Giulio Gambarota,1 Anne Vaslin,2
Peter G.H. Clarke,2 and Rolf Gruetter1
Proton spectroscopy allows the simultaneous quantiﬁcation of
a high number of metabolite concentrations termed the neuro-
chemical proﬁle. The spin echo full intensity acquired localiza-
tion (SPECIAL) scheme with an echo time of 2.7 ms was used at
9.4T for excitation of a slab parallel to a home-built quadrature
surface coil in conjunction with phase encoding in the two
remaining spatial dimensions to yield an effective spatial reso-
lution of 1.7 L. The absolute concentrations of at least 10
metabolites were calculated from the spectra of individual vox-
els using LCModel analysis. The calculated concentrations
were used for constructing quantitative metabolic maps of the
neurochemical proﬁle in normal and pathological rat brain.
Summation of individual spectra was used to assess the neu-
rochemical proﬁle of unique brain regions, such as corpus
callosum, in rat for the ﬁrst time. Following focal ischemia in rat
pups, imaging the neurochemical proﬁle indicated increased
choline groups in the ischemic core and increased glutamine in
the penumbra, which is proposed to reﬂect glutamate excito-
toxicity. We conclude that it is feasible to achieve a sensitivity
that is sufﬁcient for quantitative mapping of the neurochemical
proﬁle at microliter spatial resolution. Magn Reson Med 59:
52–58, 2008. © 2007 Wiley-Liss, Inc.
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In the past decade we and others have established that
proton MR localized spectroscopy with echo times on the
order of 2 ms allows measuring metabolite concentrations
in the brain (1–4). Approximately 18 metabolite concen-
trations that can be measured at 9.4T results in a
neurochemical proﬁle (2) consisting of putative markers
implicated in myelination (phosphoethanolamine [PE], N-
acetylaspartate [NAA], glycerophosphocholine, phospho-
choline), osmolytes (taurine [Tau], myo-inositol [Ins],
scyllo-inositol), antioxidants (glutathione and ascorbate
[Asc]), energy metabolism (creatine [Cr] and phosphocre-
atine [PCr], glucose [Glc], lactate [Lac], and alanine [Ala]),
and neurotransmitters and associated metabolites (-ami-
nobutyrate [GABA], N-acetylaspartylglutamate [NAAG],
glutamate [Glu], and glutamine [Gln]). Short echo time
proton spectroscopy enables us to quantify compounds
with spin systems including strongly and/or weakly J-
coupled multiplets as well as singlet resonances without
the need for correcting effects of T2 relaxation times. Most
studies to date have used single-voxel localized spectros-
copy to obtain such neurochemical proﬁles only from one
selected volume at a time.
On the other hand, spectroscopic imaging can be used to
obtain this information simultaneously from many voxels,
amounting to a regional mapping of the neurochemical
proﬁle. It is also likely to yield important insight in dis-
eases with complex regional distribution of metabolites
such as focal ischemia or multiple sclerosis. Most studies
based on spectroscopic imaging techniques have used long
echo times, thereby limiting the obtained concentrations
to prominent singlets of NAA, total creatine (tCr), and
choline-containing compounds (Cho), and in some cases
to a few J-coupled resonances, such as Lac and gluta-
mate  glutamine (Glx) (5,6) due to the additional signal
loss incurred by J-modulation of strongly coupled spin
systems.
A number of practical implementations of short-echo-
time spectroscopic imaging in brain have been reported. In
human studies short-echo-time measurements were used
either for obtaining localized spectra and metabolite con-
centrations from speciﬁc regions of the brain (7–14) or for
constructing qualitative metabolic maps of some metabo-
lites (15). Only the article by McLean et al. (6) showed
quantitative maps of NAA and Glx obtained with TE 
30 ms at 1.5T in a healthy human subject and in a multiple
sclerosis patient.
A few reports describe short-TE spectroscopic imaging
in animals, which was used for quantiﬁcation of metabo-
lites giving J-coupled multiplets. Juchem et al. (16) per-
formed spectroscopic imaging experiments at 7T in the
monkey brain with very high spatial resolution (4 L)
using the STEAM excitation scheme and TE 10 ms. They
quantiﬁed NAA, tCr, and Glx in gray and white matter of
the visual cortex. Geppert et al. (3) demonstrated the fea-
sibility of PRESS-based spectroscopic imaging with TE 
6 ms in rat brain. Liimatainen et al. (17) used ultra-short
echo-time spectroscopic imaging experiment (TE  2 ms)
to map lipids in treated glioma in rats. The distribution of
metabolites showing J-coupled multiplets was also
mapped using a combination of 2D spectroscopic imaging
with 2D correlation spectroscopy in a rat brain glioma
1Laboratory for Functional and Metabolic Imaging, Ecole Polytechnique Fe´de´-
rale de Lausanne, Lausanne, Switzerland.
2Department of Cellular Biology and Morphology, University of Lausanne,
Lausanne, Switzerland.
Grant sponsor: Centre d’Imagerie BioMedicale (CIBM); Grant sponsor: Leen-
aards and Jeantet Foundations; Grant sponsor: US Public Health Service
(PHS); National Institutes of Health (NIH); Grant number: R01NS042005; Grant
sponsor: Swiss National Science Foundation; Grant number: 3100A0-
116220.
*Correspondence to: Dr. Vladimı´r Mlyna´rik, Laboratory of Functional and
Metabolic Imaging, Ecole Polytechnique Fe´de´rale de Lausanne, Station 6,
CH-1015 Lausanne, Switzerland. E-mail: vladimir.mlynarik@epﬂ.ch
Received 9 May 2007; revised 17 August 2007; accepted 19 September 2007.
DOI 10.1002/mrm.21447
Published online 29 November 2007 in Wiley InterScience (www.interscience.
wiley.com).
Magnetic Resonance in Medicine 59:52–58 (2008)
© 2007 Wiley-Liss, Inc. 52
model (18,19). To our knowledge, quantitative maps of the
neurochemical proﬁle have not been reported to date.
In addition to the technical challenge of the intrinsically
low sensitivity of NMR spectroscopy, spectroscopic imag-
ing needs to contend with potential signal contamination
from extraneous lipid and water signals. Sensitivity can be
substantially improved by using a high magnetic ﬁeld,
optimized magnetic ﬁeld homogeneity, and using ultra-
short echo time. We have recently described such ad-
vances using the spin echo full intensity acquired local-
ization (SPECIAL) (20) scheme single-voxel localization,
affording about a 2-fold sensitivity gain over previous
studies. We hypothesized that these advances in sensitiv-
ity would permit imaging the neurochemical proﬁle at a
spatial resolution comparable to that achieved with map-
ping cerebral metabolic rate of glucose in rodents using
ﬂuorodeoxyglucose positron emission microtomography.
Therefore, the aim of the present study was to demonstrate
the feasibility of quantitative mapping of the neurochem-
ical proﬁle consisting of at least 10 metabolites in rodent
brain at 9.4T at about 2 ms echo time with a nominal
spatial resolution of 1–2 L.
MATERIALS AND METHODS
Animal Preparation
In vivo experiments were performed on male Sprague-
Dawley rats, which were anesthetized with 1.5–2.5%
isoﬂurane using a nose mask. All animal experiments were
conducted according to federal and local ethical guide-
lines and the protocols were approved by the local regu-
latory body. Body temperature was maintained at 37.5 
1.0°C by circulating warm water around the animals. Two
groups of animals were studied: The ﬁrst consisted of three
healthy adult rats with a mean weight of 280 g. In the
second group, which involved three 13-day-old rats, focal
ischemia was induced the day before by middle cerebral
artery occlusion according to the protocol of Renolleau et
al. (21). The main cortical branch of the left middle cere-
bral artery was electrocoagulated just below the bifurca-
tion of the middle cerebral artery into frontal and parietal
branches. The left common carotid artery was then oc-
cluded by means of a clip for 90 min. This increased the
size of the lesion and reduced variability by causing a
transient reduction of blood ﬂow into the ischemic region
via anastomoses from the anterior and posterior cerebral
arteries. Thus, the ischemia involved both transient and
permanent components. During surgery, rat pups were
maintained at 37°C in the induction chamber under 2.5%
isoﬂurane. The arterial clip was then removed and the
restoration of carotid blood ﬂow was veriﬁed under a
dissecting microscope before the skin incision was closed.
The ﬁnal MR imaging was performed on the fourth day
after the surgery. The rats were then perfused through the
heart with 4% paraformaldehyde in phosphate-buffered
saline. Cresyl violet-stained serial cryostat sections 50 m
thick were traced using a computer-microscope system
equipped with the Neurolucida program (MicroBright-
Field, Colchester, VT) and the volumes of the necrotic area
were calculated.
MRI and Spectroscopic Imaging
Measurements were performed on a Varian INOVA spec-
trometer (Varian, Palo Alto, CA) interfaced to an actively
shielded 9.4T magnet with a 31-cm horizontal bore (Mag-
nex Scientiﬁc, Abingdon, UK) and with a 12-cm i.d. ac-
tively shielded gradient set to allow a maximum gradient
of 400 mT/m in 120 s. A home-built quadrature coil
consisting of two geometrically decoupled 14-mm-diame-
ter single loops was used as both transmitter and receiver.
The static ﬁeld homogeneity was adjusted using ﬁrst- and
second-order shims using an EPI version of FASTMAP
(22).
Localizer images were obtained in the coronal and hor-
izontal planes using a multislice turbo-spin-echo protocol
(TR/TE  2000/64 ms, echo train length  8, ﬁeld of view
[FOV]  24 mm  24 mm, slice thickness  0.7 mm, two
averages, 1282 image matrix). For spectroscopy, a rectan-
gular volume with the typical dimensions of 10  2 
10 mm3 in the X, Y, and Z directions, respectively, was
excited in the brain using the SPECIAL technique with
TE  2.7 ms (20). In short, 1D image-selected in vivo
spectroscopy (ISIS) in the vertical (Y) direction was com-
bined with a slice selective spin echo in the X and Z
directions. The slice proﬁle was optimized and the chem-
ical shift displacement minimized for slice selection in the
Y direction (parallel to the plane of the surface coil) by
using a broadband (10 kHz) adiabatic full-passage pulse.
Frequency offsets for slice-selective pulses were calcu-
lated relative to the center of the metabolite spectrum
(2.3 ppm). Two free induction delays of 2048 complex
points (spectral width of 5000 Hz, acquisition time
410 ms) with this adiabatic pulse on and off, respectively,
were subtracted for each phase encoding step. The excited
transverse magnetization was phase encoded in the X and
Z dimensions using FOV  24 mm  24 mm and 32  32
phase encoding steps spanning a Cartesian sampling of
k-space, resulting in a nominal in-plane resolution of
750 m. For the metabolite maps, scans were performed
using VAPOR water suppression interleaved with three
modules of outer volume saturation as described else-
where (1) using a TR of 2–2.5 sec. For absolute quantiﬁ-
cation, water reference maps were obtained with a TR of
1.5 sec by omitting the outer volume saturation and water
suppression. The total measurement time including water
referencing was 120 or 135 min.
Data Processing
An optimized Hanning k-space ﬁlter (23) was used in both
spatial dimensions. This apodization increased the overall
signal-to-noise ratio (SNR) and restricted Gibbs’ ringing of
the spatial response function to neighboring voxels at the
expense of a slightly broadened central lobe of the spatial
response function, which was conical in the 2D spatial
domain with the full-width-at-half-maximum (the diame-
ter of a circle) about 1.4 times greater than the linear voxel
dimension (23). Thus, given the nominal voxel size of lX 
lZ lY 0.75 0.75 2.0 1.1 mm3, the effective spatial
resolution was   (1.4  lX/2)2  lY    (1.4 
0.75/2)2  2.0  1.7 mm3. Concentrations of metabolites
were calculated for each voxel in a rectangular region
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consisting of 9 to 10 columns and 11 to 12 rows in the XZ
plane using the water signal from the same voxel as refer-
ence. Horizontal dimensions of the excited volume were
selected to be larger by 15–20% than the active volume of
the surface RF coil, which reduced the chemical shift
displacement error effects of the slice selective pulses in
the X and Z directions.
The reference data basis for the LCModel (24) calcula-
tions comprised spectra of metabolite solutions as well as
a spectrum of macromolecules and spectral lines of lipids
at 0.9 and 1.3 ppm. Absolute metabolite concentrations
were corrected for different repetition times in the water
and metabolite scans and for the different T1 relaxation
times of water and metabolites assuming a T1 of 1.9 sec for
water and a mean value of 1.4 sec for the metabolites (25).
For spectra from voxels lying in the region of the optimal
sensitivity of the RF coil, the Cramer–Rao lower bounds
were typically 2–4% for NAA, tCr, and Glu, 5–10% for
Cho, Gln, Ins, Tau, and 10–20% for Lac, Glc, GABA, PE,
and Asc.
RESULTS
The quality of FASTMAP shimming over the excited vol-
ume was evaluated from scans of healthy adult rat brain
with an unsuppressed water signal. In the central part of
the excited region the water linewidth was in the range of
10–15 Hz, and only a small number of voxels (typically
20–30%), especially in the outer part of the excited region,
had a linewidth of more than 16 Hz.
The performance of the technique was tested on the
brain of three healthy adult rats. Figure 1a shows horizon-
tal and coronal views of the excited volume in the brain,
which included various cerebral structures. Its rostral part
(indicated by r in Fig. 1) contained mostly frontal cortex,
combined with corpus callosum in small regions. The
central part (m) included cortex and corpus callosum,
which was dominant in some voxels. The major structure
in the caudal part (c) of the excited region was the hip-
pocampus, which contained in some voxels contributions
from corpus callosum and/or cortex. Figure 1c shows an
excerpt of 16 spectra from the central and caudal part of
the excited region. By adding together six spectra from
voxels containing almost pure cerebral structures, such as
corpus callosum and hippocampus, the spectra of the re-
spective tissues were obtained with an SNR increased by a
factor about 1.8 compared to that from the individual
voxels (Fig. 2). A visual inspection as well as LCModel
calculations revealed that metabolite concentrations were
lower in corpus callosum representing white matter than
in hippocampus representing gray matter, with the differ-
ences being most marked for Ins (7.4  0.2 mM and 5.4 
0.2 mM in hippocampus and corpus callosum, respec-
tively, with the error limits being Cramer–Rao lower
bounds calculated by LCModel), Tau (6.0  0.2 mM and
4.8  0.2 mM), tCr (9.6  0.2 mM and 8.6  0.2 mM), and
for GABA (1.9  0.1 mM and 1.4  0.2 mM).
To illustrate the ability of the described spectroscopic
imaging protocol to quantify changes of metabolite con-
centrations at very high spatial resolution, three rat pups
subjected to middle cerebral artery occlusion were stud-
ied. Figures 3–5 show the results obtained on one of them
that is representative of all three studies conducted. Quan-
titative metabolic maps were measured 36 hr after the
onset of ischemia in the brain region delineated in the
T2-weighted images in the ﬁrst row of Fig. 3. Four days
after the surgery, MRI delineated regression of the edema
and an infarct region that extends into the lower right
corner of the evaluated region (Fig. 4a,b). The volume of
the infarct region calculated from histology was 36 mm3.
The average concentrations of 10 metabolites measured in
characteristic regions of all three rats were assessed in the
infarct region, in the edema surrounding the necrotic core,
in the normally appearing tissue adjacent to the edema
(penumbra), and in the identical area of the contralateral
hemisphere (Table 1). The quality of the achieved data is
illustrated by two examples of the LCModel ﬁt of spectra
from voxels located in the edematous tissue and in pen-
umbra (Fig. 5). Both Table 1 and metabolic maps in Fig. 3
showed more than a 50% reduction in absolute concentra-
tions of almost all metabolites in the region corresponding
to the hyperintense signal in T2-weighted images, as illus-
trated for Cr, NAA, Glu, Gln, Cho, Tau, Ins, and Glc (sec-
ond and third rows of Fig. 3). In contrast to the general
concentration decreases, however, some metabolites
showed a distinct increase in the affected hemisphere. The
FIG. 1. Spectroscopic imaging scan of a healthy adult rat brain
based on an excited volume of 10  2  10 mm3 and TE/TR 
2.7/2000 ms. (a) Horizontal and (b) coronal views (rostral [r], central
[m], and caudal [c]) of the excited slab showing involved cerebral
structures; cor, cortex; cc, corpus callosum; hip, hippocampus. (c)
A series of water-suppressed proton spectra corresponding to the
dark-shaded area in (a).
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concentration of free lipids (Lip) was increased by 50–
100% in the affected tissue. Interestingly, in what would
later turn out to be the ﬁnal necrotic region (Fig. 4c and
hyperintensity in the lower right corner of the Cho map in
Fig. 3), the Cho concentration was comparable to that in
the penumbra and contralateral hemisphere (about
1 mmol/kg), whereas it was lower in the edematous tissue
(about 0.4 mmol/kg). Gln, on the other hand, was in-
creased by about 30% in penumbra relative to the con-
tralateral hemisphere. A nonuniform increase of Lac was
also observed in the tissue surrounding the affected area.
To minimize the effect of increased water content in the
area surrounding the infarct region (26) on the metabolite
quantiﬁcation, metabolic maps of concentrations relative
to that of total Cr were calculated (fourth and ﬁfth rows of
Fig. 3). While the NAA/Cr distribution was mostly uni-
form, the relative concentrations of other metabolites ei-
ther increased or decreased in the affected area near the
infarct. Outside this area they were uniform, showing no
differences between the two hemispheres despite the fact
that the 90-min occlusion of the common carotid artery
greatly reduced blood ﬂow throughout the entire left hemi-
sphere. Glu/Cr increased by about 30% in the close vicin-
ity of the region of infarct visible in Fig. 4. The relative
concentrations of Tau and Ins decreased more than 60% in
the region of the infarct. On the other hand, the increases
in Glc/Cr, Lip/Cr, and particularly Gln/Cr were more wide-
spread: Glc/Cr was higher in about 10% of the mapped
volume, Lip/Cr was elevated in about 20%, and Gln/Cr
was higher in about 30–40% of the volume shown in the
metabolic map. The relative concentration of Lac was el-
evated in about 20% of the mapped volume; however, the
FIG. 2. Spectra of “pure” hippocampus (a) and corpus callosum (b)
obtained by summing six voxels (delineated in Fig. 1 by solid lines
for hippocampus and by dashed lines in corpus callosum) contain-
ing predominantly one type of the respective tissue and showing
narrow water linewidth. Compared to spectra from individual voxels,
the SNR increased from 13 to 25 in hippocampus (an increase of
90%) and from 12.8 to 22 in corpus callosum (72%). Arrows in the
spectrum of corpus callosum denote the most striking differences in
spectral appearance, conﬁrmed by LCModel analysis.
FIG. 3. High-resolution quantitative metabolite maps of a rat brain
36 hr after the onset of focal ischemia in the left cortex. The size of
the excited volume was 9  2  8 mm3, TE/TR  2.7/2500 ms. The
fast-spin-echo images (the ﬁrst row) were measured immediately
before the spectroscopic imaging scan. The rectangle deﬁnes the
position of 10  11 voxels shown on metabolic maps, which is
smaller than the excited volume to eliminate voxels prone to local-
ization errors (such as limited excitation and chemical shift-dis-
placement-error related effects). The position of the coronal image
across the infarcted region is indicated by an arrow. Maps of ab-
solute concentration of metabolites (in mmol/kg) as calculated by
LCModel are shown in the second and third rows; maps of relative
concentrations using the total Cr as a reference are given in the last
two rows.
FIG. 4. Evolution of the hypoxic-ischemic lesion shown in fast-spin-
echo images (a,b) of the rat brain from Fig. 3 measured 4 days after
the onset of ischemia and (c) in the corresponding histological
section. The position of the coronal image and the histological
section is indicated by an arrow.
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Lac/Cr values calculated in the infarct region were uncer-
tain because of a low SNR and increased linewidth.
DISCUSSION
As indicated previously (20), the SPECIAL selective exci-
tation scheme providing increased SNR can be used not
only for localized single-voxel spectroscopy but also for
spectroscopic imaging. This study shows that a combina-
tion of a high-sensitivity quadrature surface coil and efﬁ-
cient shimming with the SPECIAL pulse sequence enables
the acquisition of high-resolution quantitative maps of
metabolites in rat brain. The spatial resolution of these
maps is sufﬁcient for measuring the neurochemical proﬁle
in subtle cerebral structures or for studying spatial distri-
bution of changes in metabolite concentrations induced by
a focal insult. The optimized experimental conditions al-
low a decrease in the volume necessary for determining
the neurochemical proﬁle at 1–2 L spatial resolution with
an echo time of a few ms. This volume size is comparable
to that achieved in high-resolution positron emission to-
mography in rodents (27).
For achieving sufﬁcient SNR in spectra measured from
extremely small volumes, prolonged scan times are neces-
sary. From this point of view the necessity to acquire the
minimum number of two scans in each phase encoding
step with the SPECIAL localization scheme is not restric-
tive. The measurement time can be further reduced by,
e.g., elliptical sampling of the k-space.
The relatively short repetition time used in our protocol
affects quantiﬁcation of some metabolites. A brief calcula-
tion shows that if the true T1 values of the metabolites lie
in the range of 1.04–1.67 sec (25), this error is less than
6%. The error should be higher for Tau, which has a longer
T1 of 2.3 sec, and for Lip at 1.3 ppm having a shorter T1 of
about 0.6 sec. Thus, the concentrations of Tau and Lip
shown in the metabolic maps in Fig. 3 should be multi-
plied by 1.25 and 0.85, respectively.
Compared to single voxel spectroscopy, which has
achieved linewidths of 9–13 Hz over time in our labora-
tory at 9.4T (unpubl. obs.), the linewidth in spectra of
some voxels was increased, due to uncompensated higher-
order inhomogeneity terms. Instabilities, such as the drift
of the static magnetic ﬁeld, can increase the apparent
linewidth due to the scan time on the order of 1 hr. Such
instrumental limitations may have contributed to a less
reliable quantiﬁcation of pairs of metabolites having spec-
tral lines with almost identical spectral appearance such
as Cr/PCr or glycerophosphocholine/phosphocholine.
Nevertheless, the data obtained on healthy rat brains dem-
onstrate that shimming larger volumes with FASTMAP
provides satisfactory linewidth over the entire volume
with only small regions of increased inhomogeneity.
The high spatial resolution achieved with our protocol
enables us to measure spectra from subtle and irregularly
shaped cerebral structures such as the corpus callosum by
summing spectra from voxels comprising the same tissue
(28). An increase of SNR to 22–25 was observed in the
spectra summed from six voxels. This increase was lower
than the square root of the number of summed voxels,
FIG. 5. LCModel ﬁt of spectra from voxels located in penumbra (a)
and in the edematous tissue (b) of a rat subjected to focal ischemia.
The position of the voxels is depicted in Fig. 3. The individual ﬁtted
spectra of the most relevant metabolites, the lipid signal at 1.3 ppm,
and the macromolecules are also shown.
Table 1
Absolute Concentrations of Brain Metabolites Averaged Over Three Rat Pups 36 hr After the Onset of Focal Ischemia
Metabolite
Concentration (mmol/kg)
Infarct region
n  5a
Edematous tissue
n  14
Penumbra
n  13
Contralateral hemisphere
n  13
Cr 2.0  1.2b 2.1  1.6 7.3  1.0 7.6  0.5
NAA 1.3  0.8 1.5  1.1 5.3  0.9 5.9  0.4
Glu 2.9  1.1 2.5  1.8 6.6  1.1 7.0  0.7
Gln 1.4  0.8 1.3  1.0 3.7  0.6 2.8  0.3
Cho 1.0  0.5 0.4  0.2 1.1  0.3 1.3  0.2
Tau 1.5  1.4 2.6  1.8 8.6  1.4 9.4  1.2
Ins — 0.6  0.5 2.3  0.5 3.5  0.4
Glc 1.1  0.7 1.7  1.1 4.4  0.6 4.7  0.8
Lip (1.3 ppm) 34  24 49  25 22  19 14  9
Lac 1.0  0.6 0.7  0.5 1.0  0.7 0.9  0.3
aThe number of voxels taken in statistics.
bArithmetic mean  standard deviation.
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possibly due to correlation of instrumental components of
the noise. The concentrations of Cr, Ins, Glx, and GABA in
white matter (corpus callosum) were lower than those in
gray matter (hippocampus), similar to observations in hu-
man brain (6,29,30).
Application of the technique to the rat brain with a local
infarct demonstrates its high sensitivity in detecting
changes of metabolite concentrations. When interpreting
these metabolic maps one should be aware that the con-
centrations calculated for corner voxels of the depicted
area are not reliable, as these voxels lay outside the active
volume of the RF coil and had extremely low signal inten-
sity. The overall high quality of spectra from individual
voxels enabled us to quantify 10–13 metabolites with Cra-
mer–Rao lower bounds less than 20%. The sharp bound-
ary between higher and lower absolute metabolite concen-
trations in the metabolic maps coincides with the extent of
edema in the anatomical images and illustrates the high
spatial resolution. The decrease of the absolute metabolite
concentrations in the edematous region was attributed to
changes in concentrations rather than increased water con-
tent, which may result in overall underestimated metabo-
lite concentrations, since the water signal was used as
reference for quantiﬁcation. However, water content can
increase at most from 75% for white matter to 100% (cyst,
CSF), which is several-fold smaller than the observed con-
centration changes. Moreover, the T1 relaxation time of
water in edema is typically longer than in normal brain
tissue, which would reduce its signal due to T1 saturation,
offsetting the effect of increased water.
A highly resolved spatial distribution of the neurochem-
ical proﬁle in the infarct region and in the penumbra in
rats with focal cerebral ischemia was observed and corre-
lated with MR images and histology for the ﬁrst time.
Some of the observed changes in metabolite concentra-
tions are in agreement with previous studies. The increase
of lactate and lipids in the infarct region was found by
Harada et al. (31) using localized proton spectroscopy.
Similarly, a large increase in tissue choline concentration
was reported in ischemic cortex (32). An increase of cho-
line and free lipids in the ipsilateral striatum 2 weeks after
90-min middle cerebral artery occlusion in rats was also
reported by Wang et al. (33). Using proton spectroscopic
imaging, Igarashi et al. (34) reported a transient increase of
Lac and GluNAA in both the ischemic core and rim, and
of GlnGABA in the ischemic rim 10 hr after the onset of
permanent focal cerebral ischemia in rat. The increased
Gln concentration was also observed by Haberg et al. (35)
in an extract from ischemic rat penumbra. The larger ex-
tent of increased glutamine relative to increased glutamate
likely reﬂects conversion of extracellular glutamate to glu-
tamine by healthy astrocytes outside the ischemic region,
consistent with increased excitotoxicity observed in hy-
poxic-ischemia. Changes in the activity of glutaminase and
glutamine synthetase may also play a role (36). Conﬁrma-
tion of underlying mechanisms of such changes in distri-
bution of these and other metabolites requires a more
complete study that is beyond the scope of this article.
We conclude that measuring high-spatial-resolution
quantitative metabolic maps is feasible on an animal scan-
ner at ultra-short echo times, with the beneﬁt that effects of
transverse relaxation and J-evolution on the quantiﬁcation
can be neglected. The spatial resolution of the metabolic
maps is comparable to that achieved on animal positron
emission tomography scanners, e.g., for mapping the cere-
bral metabolic rate of glucose.
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